StemCell Therapy

Dr. Evelyne Bischof speaking at the 2020 China-Israel Summit on Longevity Medicine

Over the past decade, we witnessed unprecedented advances in the field of biogerontology, and the massive convergence of biotechnology, information technology, AI, and medicine. And now we are witnessing the birth of a new field of longevity medicine, which integrates the latest advances in many of these fields of science and technology. My definition longevity medicine is advanced personalized preventative medicine powered by deep biomarkers of aging and longevity.

And, like in the field of AI for drug discovery, women are at the forefront of this revolution and there were precedents when we had to look for a male physician to make a conference panel more diverse.

One of the physician-scientists who stands out in this area is Dr. Evelyne Yehudit Bischof. I first got a note with a request for more information on one of our research papers from Dr. Bischof on December 30th, 2019 while in Shanghai. A request I almost ignored due to the heavy workload but accidentally I looked at her profile which was highly unusual. In brief, Evelyne is a German medical doctor with an MD from Max Planck Institute for Molecular Biology and Genetics, who interned at Columbia University, and Harvard MGH and Beth Israel Medical Deaconess, attending physician at University Hospital Basel in Switzerland, and associate professor at Shanghai University of Medicine and Health Sciences. She fluently spoke six languages including German, Russian, and Mandarin Chinese, which was quite impressive. The second time we met was at Human Longevity Inc, in San Diego when she was interviewing with one of the most influential entrepreneurs and investors in longevity biotechnology, Dr. Wei-Wu He to join HLI as a longevity physician.

Dr. Evelyne Yehudit Bischof

The longevity industry is rapidly emerging and longevity clinics are being set up in various parts of the world. So I decided to ask Eva a few questions to elucidate this new and emerging industry.

Alex: Eva, we know each other for almost a year and you do not fail to impress with your academic publications, public lectures, and clinical work. You are as close to the longevity physician as it can possibly get. Can you tell us a bit more about yourself and about the work that you are doing on the clinical side and on the research side?

Dr. Evelyne Bischof: Thank you, Alex it is an honor to be so generously introduced by a true innovator, scientist and entrepreneur, as well as a longevity KOL and allow me to revert the compliment. I am a rather globally oriented internal medicine specialist, with training and work experience in Germany, USA, Switzerland and China. For almost a decade now, I have been splitting my time between Shanghai and Basel, creating a path that allowed me to conclude my residency and fellowship, develop translational and clinical research niches and collaborators, as well as to engage actively in academic medical education. While my clinical work was mostly based in a university clinic in Basel in internal, intensive and onco-hematologic medicine wards, my scientific pursuits and academic teaching were mostly based in Shanghai, where I went along the track from a junior lecturer to an associate professor in 2016. My research focused primarily, but not exclusively, on oncology and being an internist at core on geroncology and precision medicine in general internal medicine. Geroncology is a crucial field that investigates the very much interlinked pathways of aging and tumorigenesis, leading to the epidemiological observation that age is the number one risk factor to develop cancer for all.

Both Switzerland and China are innovative hubs with strong medical and bioscientific profile, which allowed me to learn from some of the finest experts worldwide. The frequent travels and splitting my life between continents were not always easy, but - coming from a simple background of non-academic farmer and handcraft family Alongside - I will be forever grateful for all the great people I met and worked with, the abundant cultural nuances and differences I was able to learn and appreciate, the stimulating and constructive exchange and so much more in soft and hard skills, on professional and personal level. with the emergence of AI-based solutions in the clinic and with the rise of longevity medicine, my passion and efforts are now focused on these domains, while I continue my clinical practice in the university hospitals, academic lecturing at two medical schools (currently in Shanghai - due to COVID-19-related travel restrictions) and research/public speaking (globally - thanks to COVID-19-related shift to virtual communication).

Alex: Can you tell us about your perspective on the emerging field of longevity medicine starting from your own definition of the field?

Dr. Evelyne Bischof: With pleasure! My personal definition of longevity medicine is clear: it is precision medicine driven by deep aging biomarkers. Surely, the definition is succinct, but extremely deep. Precision medicine is per se an enormously complex and dynamic field, driven by multimodally mined data and their constant re-evaluation, reannotation and reiteration to provide qualitative and quantitative using AI-algorithm outputs applicable for clinical practice. Longevity medicine is a to say the next generation of precision medicine that evaluates the patient within the reference range for the patients ideal age (usually 20-30) and is looking for ways to reduce the gap between the current parameters and the parameters of maximum physical performance for the ideal age. Deep aging clocks as quantifiable, trackable and accurate biomarkers of aging and an indispensable component of longevity medicine. Without being able to actually measure the biological age and its changes due to interventions, longevity medicine cannot be performed. I strongly believe that this field of medicine will revolutionize healthcare and change the mindset of all the doctors, the policy makers, the stakeholders and above all: the patients. Allow me to add that I consider each of us as a patient we all suffer from aging! I also believe that citing Peter Diamandis in the future, if a physician wont be using A.I. in guiding diagnosis and therapy, it'll be a malpractice". This said, I would love to add that we need more passionate physicians in longevity and this can only be achieved with an appropriate educational setting, which will be inaugurated this month by Deep Longevity and collaborators.

Alex: What do you see as the most promising developments in the field of longevity medicine that can truly push the needle and add a few decades if not more to the healthy youthful life of the individual?

Dr. Evelyne Bischof: Besides of deep aging clocks and AgeMetrics, which I truly without cronyism embrace and would encourage all physicians to implement in their daily practice, I see a big potential in gene therapies, in (natural and designed) gerolytics and senolytics, as well as supplements that will show safe efficacy in combating senescence from the molecular to system level. Studies on AKG, rapamycin and metformin are already fueling this hope. Of course, all interventions will require a prior comprehensive precision health assessment and continuous monitoring. For the latter, the wearables and applications will certainly bring us even faster to an extension of a healthy and productive lifespan.

I am encouraged by the fact that there are two major developments, perpetuated by the racing speed of longevity medicine and geroscience. Number one: doctors are shifting from putting a patient on meds to putting a patient on a personalized longevity protocol that becomes a natural, integral, rewarding part of their lives. Number two: society is realizing that it is not important how old one is, but how one shows his/her own age. Remembering this allows one to make sure he or she does not become a slave of the myths about the elderly, but also to be mindful that even at an early chronological age, one might actually experience silent accelerating aging due to modifiable risk factors or pathomechanisms.

Alex: Without promoting Human Longevity Inc or Health Nucleus 100+, can you tell us what an average person with an average income can do to increase their performance and longevity?

Dr. Evelyne Bischof speaking at the 2020 China-Israel Summit on Longevity Medicine

Dr. Evelyne Bischof: This is a very valid question in fact, when it comes to reasonably boosting performance and creating a good base for longevity, one does not necessarily be wealthy. The components of the magic mixture are the well-known pillars of preventative and functional medicine: exercise, nutrition, supplements, moderation. However, longevity physicians are now able to customize the right proportions of each for a specific person, minding the biovariability, comorbidities, chronological age, but also lifestyle and preferences. In an extreme generalization, I would suggest caloric restriction via intermittent fasting to an overall healthy person, with at least an A-Z vitamin and mineral supplement, 15-30min workout at least 3 times a week, moderation in substance use to the minimum, but with permissible enjoyment, if needed (alcohol and cigarettes), a minimum of 6 hours of sleep without interruption, circadian rhythm (regular times) of sleep and food intake, no meals at night (at least 4 hours before night rest) and very importantly cognitive activities (books, foreign languages, crosswords), preferably rewarding ones so that the psychological wellbeing area is also covered. Everyone is able to use stairs as their gym, to not to eat before sleep, to choose water over other drinks, to laugh aloud to oneself and to learn text parts by heart (because decelerating psychological aging and cognitive decline are crucial aspects of healthy longevity). I recall I was always reading the ingredients and how to use? texts on tubes during shower, so as not to waste the time. My first sentence in Russian was actually the instruction of how to use a shampoo.

Dr. Evelyne Bischof speaking at a conference on aging and longevity

Alex: And if someone has nearly unlimited access to capital, what should they do?

Dr. Evelyne Bischof: I believe, as in any other business or property of this particular population, the individuals should seek good investments and insurance in relation to their health and the health of their significant surrounding (family, friends, workers etc.). The investment should involve as precise diagnostics as possible, that harnesses all cutting edge and untapped potential of the human genome, deep quantitative phenotyping, complete -omics and -ioms (e.g. microbiome, epigenomics, metabolomics, proteomics etc.), advanced imaging with radiogenomic algorithms etc. As it is a dynamic field, constantly evolving and implementing new features and/or better ways of interpretation, such diagnostic comprehensive checkups (or part of them) should be repeated regularly. The insurance part does not relate to a contracted policy, but to a complex entity of lifestyle recommendations and interventions lead by an entrusted longevity physician (basically a physician that can list and pronounce the aforementioned terms), who understands and permanently advances in the field, being able to combine human and artificial intelligence and customize an individual approach of prevention and (if needed) therapy for a specific patient. In addition, the leading physician needs to comprehend and implement the personal challenges and preferences of the patient, such as mostly disturbed wake-sleep rhythm, irregular and unhealthy social meals, acute and chronic stress exposure, irritability or fatigue etc., to create a program that will be realistic, allow the patient to remain compliant and engaged based on his/her educated informed decisions. Simply said: knowing 150 GB of a patients data, a physician of trust should be a good lead towards identification, mitigation and elimination of actionable diseases (years and decades ahead) and risk factors that curb the quantity and quality of life.

Alex: I know maybe 3-4 people like you in the world, who have an MD, are actively engaged in biomedical research, and work with some of the high-profile clients who are spoiled with the most cutting-edge medical care provided by the top medical institutions. And all of them are women. Why do we see such gender imbalance in the field?

Dr. Evelyne Bischof in the clinic

Dr. Evelyne Bischof: Again thank you very much for this encouraging statement, this time speaking on behalf of women in medicine, academia and STEM. As you know, one of my side areas of interest is the study of biological sex differences in various diseases, predominantly cancer, and ultimately also on the sex (biological) and gender (socio-cultural) variables influencing pathomechanisms, diagnostic and therapeutic decisions, resulting differing toxicities, follow up strategies and outcomes (recovery, chronification etc.). It was natural to engage in debates and develop curiosity about the gender distribution in academia in general. Recently, with an ad hoc group of collaborators from Europe, USA and China, we demonstrated in a Lancet Oncology paper that female representation at the podium, meaning as keynote speakers and scientific committees at the largest oncological conferences in China. Our data showed that China is much more inclusive, without an intensive active promotion or directives towards gender quotas. As you know, I am a big fan of this country, but this quantitative study once again showed how impressive this country is and perhaps we found one of the contributing factors for the nations booming leading role in biotech and medicine.

Overall however, there are indeed significant differences in various fields, as well as an overall underrepresentation of females in leadership and podium roles. I am happy to see that in longevity science and medicine, we have dedicated females that can unfold their passions and translate them into viable solutions that do impact the public and individual health. As always, the reasons are multifold, but perhaps the most important one is that in longevity, driven women are emerging in an inclusive environment that embraces non-discriminating and non-stigmatized diversion. In different words: the longevity field seems to embrace inclusion at the same (ultrarapid) pace as STEM and medicine are evolving. The sex and gender differences clearly allow to generate creativity and innovation it is a mutually perpetuating process. Last but not least, it is thanks to committed male mentors and collaborators that actually value D&I (diversity and inclusion) intuitively or knowingly (based on evidence that diverse teams outperform the less diverse one by over 35%). Most male KOLs in longevity, like yourself, promote and underline the importance of D&I. On a final note myself, personally, I have always remained at the unconscious side when facing a person I work with. Accountability, motivation and fairness have proven to be non-gender related in my experience as I have faced many challenges being a (previously young) female, permanent foreigner and on top of that blond. The typical situation at a round dinner table in China with 12 male professors usually ended up with us all laughing at my gambei with water being the only discrepancy from the norm.

Dr. Evelyne Bischof speaking at the 2020 China-Israel Summit on Longevity Medicine

Go here to read the rest:
Women In Longevity Medicine And The Rise Of The Longevity Physician - Forbes

By Dr. Monica Capella l Associate Veterinarian, VCA Calvert Veterinary Center

With the fall weather comes the beautiful parts of the season carving pumpkins, apple pies, the changing of the leaves and the excitement of Halloween. With the hocus pocus, spooky ghosts and holiday fun also comes one of my favorite parts of all the candy! Its no surprise that our furry friends also find these sweet treats appealing, but for them, there are real dangers hiding behind the shiny wrappers.

Chocolate toxicity is a common problem we see this time of year in veterinary medicine, and we are going to go through what signs to look for in your pets, some tips and tricks for minimizing exposure for your pets, and helpful resources for owners to contact in the event of ingestion. At the end of this article, we will also highlight some major points about xylitol toxicity.

There is a significant variation in how your dog may respond to chocolate toxicity relative to other dogs. Smaller dogs and pre-existing conditions like liver, kidney, heart and neurologic disease may make your dog more susceptible to chocolate toxicity. Mild to moderate signs we look for in dogs are vomiting, increased urination, diarrhea and restlessness. Additional warning signs can include agitation, hyperactivity, ataxia (stumbling gait), increased heart rate, breathing faster, high temperature and high blood pressure. Severe toxicity may cause tremors, seizures, severe abnormal heart rhythms, coma and death, which is why identifying exposure and being as informed as possible is critical when contacting an animal poison control center.

Tips And Tricks For Owners

Helpful Links/Resources For Owners

https://veterinarypartner.vin.com/default.aspx?pid=19239&id=4952115

https://veterinarypartner.vin.com/default.aspx?pid=19239&id=6107960

Xylawhat? Xylitol!

Xylitol is a sugar substitute compound that has become more popular in todays market and is found in products like sugarless gum, toothpaste and certain brands of peanut butter. Your dogs normal response to sugar intake is the same as in the human body ingestion of sugar leads to release of insulin to help move that sugar into the tissues to be used for energy. The problem with Xylitol is that we can see an increased release of insulin (three to seven times greater) in dogs, leading to severely low blood sugar. Signs can include vomiting, tremors, incoordination, collapse, and seizures within 30 minutes 12 hours of ingestion. Unfortunately, Xylitol ingestion in dogs can be a two-part problem as the liver becomes affected, leading to acute liver failure, bleeding and clotting problems. If you suspect your dog has ingested Xylitol, contact your veterinarian and poison control center immediately to learn the next steps and have your pet evaluated.

Helpful Links/Resources For Owners

In regards to chocolate and Xylitol toxicity for your pets, the best medicine is preventative medicine. Staying informed and limiting your pets risk of ingestion will help make this fall season safe and enjoyable for everyone in the family, including your canine and feline companions. The veterinarians and staff at VCA Calvert Center thank you for your time and dedication to the care of your pets, and they are available by phone or email if you have additional questions or concerns. We wish everyone a season of safe and happy memories during these times!

The veterinarians of VCA Calvert Veterinary Center have over 35 years of combined experience helping pets stay healthy and happy. For more information about how to care for your exotic pet, call today for an appointment at 410-360-PAWS or schedule online at http://www.vcahospitals.com/calvert. VCA Calvert Veterinary Center is conveniently located at 4100 Mountain Road and has been proudly serving the Pasadena community for over 16 years.

See the article here:
The Dangers Of Chocolate And Xylitol Toxicity In Dogs And Cats - Severna Park Voice

In the days after it became clear that the White House had suffered a COVID-19 outbreak, many who had been in the building or interacted with the President wondered aloud: why hadnt they heard from contact tracers?

But though the idea of a legion of agents armed with the know-how to trace and detect an outbreak may be comforting, its one of a series of misconceptions that surround the idea of contact tracing in the U.S.

Though the concept has been successfully implemented in countries around the world and in a few locations here, the U.S. as a whole lags far behind where it needs to be in order to have contact tracing function as an effective tool to mitigate and control the pandemic.

Beyond the lack of infrastructure, personnel, and funding for the local public health departments that conduct contact tracing, the approach also faces a conceptual problem due to the massive amount of virus that continue to spread across the country.

Theres just too much viral load for contact tracing to be effective right now, Gary Slutkin, a former WHO epidemiologist who fought disease in Africa, told TPM.

Whats left is a bleak but revealing picture: a key tool needed to bring the pandemic to an end is missing.

Contact tracing operates on a simple principle: if you can identify who an infected person has been in close contact with, you can get ahead of COVID-19 by quarantining those exposed to the virus.

The approach is an essential component of any pandemic mitigation and prevention strategy, allowing public health officials to catch and halt transmission chains as they occur.

But its a huge ask. A report from the Association of State and Territorial Health Officials estimated that nearly 330,000 contact tracers would be needed nationwide, assuming a ratio of one contact tracer per one thousand citizens.

And contact tracing is most suited for the beginning and ends of the epidemic curve,Josh Michaud, associate director for global health policy at the Kaiser Family Foundation, told TPM times whencases are few enough that individual outbreaks can be tracked down and potential cases contained.Thats not the situation the U.S. finds itself in today, with only somewhat-mitigated spread.

In places where you have a city or a county or something where theres just widespread transmission, too many cases to count, in that kind of situation you dont see contact tracing having much of an impact, Michaud said.

Coupled with the overwhelming rate of new cases in the U.S., slow testing turnaround times and lack of resources for the local public health departments that actually trace contacts drastically reduce the effectiveness of an already sparsely used program.

If results are being delayed 7-10 days, contact tracing almost is worthless because you cant identify people quickly before theyve already spread the virus, Michaud noted.

Public health departments around the country are already equipped to handle the function in limited ways due to past experience with tuberculosis and HIV/AIDS, Dr. William Schaffner, a professor of preventative medicine at Vanderbilt University Medical School, told TPM.

Its traditionally done at the local level, by the city or county health departments, and it takes some training, he added. It depends on gaining the trust of the person whom youre interviewing for the case.

We havent had a lot of resources, Schaffner added.

Congress appropriated $25 billion for COVID-19 testing and contact tracing in March as part of the CARES Act.

But since then, no new federal dollars have been earmarked for the task.

Experts told TPM that in an ideal scenario, COVID-19 transmission would be reduced to a level where contact tracing would be effective: individual outbreaks could be caught and stopped by local public health departments.

If you think of the population as being infected in a more circumscribed way the White House, for example contact tracing there can be very, very helpful, Schaffner added. You can button things up in that particular population. But if you think of our population at large, regardless of what were doing with contact tracing, it has a much less notable effect.

And though some areas like New York City have managed to stand up groups of contact tracers to try to identify and halt new outbreaks as they occur, many areas with underfunded health departments have had trouble finding the money and time to track down the contacts of people infected with COVID-19.

Several proposals would see billions of dollars go towards local public health departments, allowing them to hire scores of contact tracers that would be able to meet the level the country needs to keep virus transmission at a level far lower than it is today.

ASTHO and Johns Hopkins released an estimate saying that 100,000 contact tracers was the minimum needed nationally to rapidly identify, contain, support, and re-testindividuals who are infected and have been exposed.

The Biden campaign has latched onto that number, committing to establishing a U.S. Public Health Job Corps that would be composed of at least 100,000 people to work on public health issues around COVID-19, including contact tracing. Biden has also said that he would establish a U.S. Public Health Service Reserve Corps that would deploy around the country to train local health departments to detect and respond to COVID-19 outbreaks.

Other questions around massive budgetary losses in local government linger. Public health departments are already constrained by a steep drop in tax revenue, making it difficult to add more services.

The HEROES Act, House Democrats bill aimed at addressing the pandemic, includes a $75 billion appropriation for testing and contact tracing which would go part of the way towards addressing this.

But, Michaud argued, to have avoided outbreaks in the fall and coming winter, the country should have made these investments months ago.

The time to invest was yesterday, he said. We needed to make sure to have those in place for what could be a surge in cases going forward as the weather gets colder.

See the rest here:
White House Outbreak Exposes Contact Tracing-Shaped Hole In US COVID Response - TPM

BrandonFlanery

bflanery@uccs.edu

Can you be LGBTQ+ and Christian?

Thisquestion is critical, as itstheprimary reason why U.S. Americans are leaving evangelical churches.

According to Public Religion Research, 70 percent of millennials are alienatedbychurchesjudgments towards LGBTQ+individuals, and with good reason.

According to the Trevor Project, LGB youth are almost five times as likely to have attempted suicide compared to heterosexual youth, and according to the American Journal of Preventative Medicine, religious LGBTQ+ youth are significantlymore likelythan their non-religious peers to attempt suicide.

We cant afford to not have an informed opinion on this. There are literally human lives at stake, andunless youre burying yourself underground (literally or symbolically),you willcome into contact withLGBTQ+peopleat some point in your life.Were statistically everywhere. Shoot, you might even have one as a kid. What are you going to do then?

With all that in mind, my hope is that I can help you start the journey with this article.

First off, why me? Well, because Im Christian, gay, was raised in the church, worked in ministry,Ileft ministry and Christianity because of the pain I endured. But Icame back, researched and prayed through my position on being gay and Christian, and Im now buildingbelievr, an app that exists tohelp LGBTQ+ Christians find belongingandconnection in love.

I dont say that to toot my own horn. Its to help build some ethos as quickly as possible(after all, Im already breaking the character limit; my editor is going to kill me).

So,forsakeof brevity,Im going to point you to two amazing resources that will elaborate far more succinctly that I ever willbe able toin a short article. TheReformation Project and Beloved Ariseare two organizations that havecatalogued resources like books and videos by scholars to show you that it is okay to be queer and Christian.

Readingany of the books they recommend is a great start. In summary, they will all tell youthe same thing: the condemnationofLGBTQ+ peopleiswrong, andany verse thatalludesto the condemnation of LGBTQ+ peopleismissing context and has been mistranslated over the centuries.In fact, most of the verses about homosexuality inthe Biblewere translated as pedophilia all the way upuntilthe 1950s.

But Ill let the experts speakonthis,because theyll do a far better job. What I want to do in this article isa little more meta. I want tobring into question what it means to be a Christian and how that affects those whoare LGBTQ+.

When growing up,I was told insensately, Christianity isnt a religion; its a relationship. Heres the problem: I would hear it from the most religious people. Heres the other problem: even though itsa hypocriticalclich, theyre right.

Religion says, Heres what you do to please God Heres what you do to get to Heaven Heres what you do to be a good (insert religiousnoun)

Its all about whatthe humandoes in relation to the deity in question.

Thats not what Jesus came to do; He didnt come to create a new way of getting to God.

The reason Christianity (in its purest form) isactually differentthan all other religionsis that humanity had been trying to get to God for millennia, and we werent able. Were not able.Instead, God said, Im coming to them, and Im making all this right.

The word gospelliterally translates to good news. If were talking about another way to get to God, thats not good news. None of us can make it, regardless of what the magic formulais.Thats thepointof the Bible hundreds of humanstooka good shot at getting to God,and none of them did.So,God had to come to us.

Christianity is truly just about trust.Its not about what I do to get to God, including my sexuality.Its about knowing humanity has done a shit job of being perfect. We keep fucking it up. We were never enough. But Jesus was enough, andtrustingin His love, in His goodness,leads us to loving Him and loving others. Thats the work of Christianity.

I want to pointtotwo places in the Bible to make a point here.

The first one is Genesis 1-3 (you know, the verses that make it so that Christians dont believe in evolution). In this story Adam and Eve ate from theTree of theKnowledge of Good and Evil (religion), and it cursed them and all of humanity. If we continue to live out of this tree of religion, were going to keep cursing humanity. Just look at historyanyone heard of the Crusades? Or the wars in Ireland? Or whats currently happening inKashmir?

Instead, were called to life in the Tree of Life, which is living in connection to Jesus (relationship),who is the embodiment of Love.

Which brings me to my next story in Acts 15.

In short, heres what happened:non-Jews, or Gentiles,were becoming Christians;Jewish Christianswere complaining they werent obeying the law; everyone was confused on what to do. Were these Christians who wouldnt obey the law actually saved?

Heres the crazy part, and not a ton of Christians talk about this.

In response to this unrest, the 12 disciples of Jesuscame together at the Council of Jerusalem andprayed. After which, they decided thatGentileChristiansshouldfollow threerules.

What? Can humans just change the rules? They can if theres a higher rule that is helping them navigate the world. A new commandment I give you:Love one another. As I have loved you, so must you love one another(John 13:34).

Jesus came to fulfill the law, to fulfill religion,because we couldnt make it to God. After He took care of it all, He says, Go love.

The reason the 12 disciples of Jesus gave instructions (not laws)to theseGentileChristianswas not becauseJesus got it wrong.They were fulfillingHis new instruction; they wereteachingthe firstChristians tolovepeople in a new context that was foreign to them.

And thats what Christians are called todo to love God and people inourcurrent context. Andaccording to that context,wevalue women,we valueegalitarianism,we value racial justice, we value equity,andwe value ourLGBTQ+brothers and sisters because they are worthy of love.

The culture to which the Bible was written used sodomy as a way of degrading conquered nations, of using power to abuse those who were powerless. It wasnt abouta sharedlove. That wasnt their context. But that is our context now, and Christians can fulfill the words of Christ,loving our neighborsby believing and trusting that their LGBTQ+ brothers and sisters and non-binary siblingsareloved in the eyes of God,andthatHis sacrifice through Jesus was more than enoughfor us all.

Regardless of gay or straight, cis or trans, none of us could make it and all of us believed God was cruel. The message of Christ is that He was able and that He is love, if we believe.

Who then is the one who condemns? No one. Christ Jesus who died more than that, who was raised to lifeis at the right hand of God and is also interceding for us. Who shall separate us from the love of Christ? I am convinced that neither death nor life, neither angels nor demons, neither the present nor the future, nor any powers, neither height nor depth, nor anything else in all creation, will be able to separate us from the love of God that is in Christ Jesus our Lord(Romans 8:34-39).

Read more:
Can you be LGBTQ+ and Christian? - The Scribe

Sure, people wear face masks these days mostly to help prevent the spread of COVID-19. But now experts say there might be an added benefit of wearing your mask when out in public: It could lower your odds of contracting the flu.

Like COVID-19, the flu is a virus thats mainly spread through infected respiratory droplets. Wearing a mask will likely decrease transmission of the flu as well, says Richard Watkins, MD, an infectious-disease physician in Akron, Ohio, and a professor of internal medicine at Northeast Ohio Medical University.

Rajeev Fernando, MD, an infectious-disease expert in Southampton, N.Y., expects that the 2020-21 flu season will actually be milder than usual because of coronavirus-prevention methods, including widespread mask wearing. Its the same concept as preventing the spread of COVID-19, he says. Masks can help prevent respiratory droplets from spreading.

That being said, you should still plan on getting a flu shot and practicing other flu prevention methods this year. Here's what you need to know about protecting yourself from the fluvia face masks and other measuresthis year.

FWIW: The Centers for Disease Control and Prevention (CDC) does not currently list wearing a face mask in its main recommendations for preventing the spread of the flu. Instead, the CDC recommends avoiding close contact with people who are sick, covering your coughs and sneezes, washing your hands well with soap and water, avoiding touching your eyes, nose, and mouth, and cleaning and disinfecting objects that could be contaminated with the viruses that cause the flu.

However, the CDC does point people to everyday preventative measures for stopping the spread of COVID-19 as part of its tips for preventing the spread of the flu. And among those measures is advice to wear a face mask whenever you go out.

Medical staff wear surgical masks when treating flu patients, Fernando says, and a cloth face mask can likely offer at least some level of protection. And if someone who has the flu wears a mask and the people around them also wear a mask, the odds of the infected person making others sick drops dramatically, Fernando says.

The CDC specifically says that getting vaccinated against the flu this season is more important than ever and lists these as important reasons to get your shot:

At this point, I would recommend as many preventive measures that we know are successful, Fernando says. Theres really no reason not to get your flu shot. We will have a weaker flu season if everyone does that.

This content is imported from {embed-name}. You may be able to find the same content in another format, or you may be able to find more information, at their web site.

And, if you continue to practice known ways of preventing the spread of COVID-19, like wearing your mask, avoiding crowds as much as possible, social distancing, and washing your hands regularly, your odds of contracting the fluand COVID-19should plummet, Watkins says.

Sounds like a win-win.

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

Excerpt from:
Will a Face Mask Protect Against Both The Flu And COVID-19? Here's What Doctors Say - Women's Health

Investments into precision medicine companies is rising, but how much has it helped?

What healthcare will look like when the COVID pandemic is over is tough to say right now. What new technologies will emerge from this? What new data sets are created and how they are shared? Will healthcare shift to being more preventative? That will likely take years to sort out.

One interesting thing to look out for will be if we see a rise in precision health. This is healthcare that is tailored to each individual person, using their genes to figure out what treatments will work best for them. In a pandemic like COVID, knowing how to treat each person, and what drugs they will react best to, could have saved countless lives.

Precision health, however, didn't see the same type of rise in adoption as a space like telehealth, which a recent reportspeculated would encompass over 20 percent of all patient visits this year,representing $29.3 billion of medical services. Perhaps the difference is that telehealth services have been around for a long time, even if nobody was really using them before they were forced to; precision heath, on the other hand, is a relatively new space. The Human Genome Project was only completed in 2003, after all.

Still, the pandemic does seem to have increased investor interest in the space, which perhaps shows that they are betting on it to take on a bigger role if we were to go through another similar pandemic (knock on wood!).

In 2018, there was $565 million invested in 17 deals into startups using artificial intelligence to improve precision medicine.

In Q2 of this year, there was $5.1 billion invested in the healthtech space, representing 22 percent of all VC dollars invested during the quarter. Of that, $2.6 billion came from Series A investments into biopharma companies, compared to $2.3 billion in all of 2017.As such, valuations for these companies have increased by at least two-fold since the start of 2019.

There are also digital therapeutics, which compromises precision medicine. Thesetherapeutics interventions are driven by software programs that use data to prevent, manage, or treat disorderand diseases. Investments in this category have grown an average of 40 percent year-over-year for each of the the last seven years; it reached $1 billion in 2018.

Another subset of precision medicine ispredictive analytics, which uses data to predict what will happen to each patient, and to personalize their care based on those outcomes. This is a market that is expected to reach $7.8 billion by 2025.

Some of the biggest precision medicine companies include 23andMe, which has raised $786.1 million; Tempus, which has raised $620 million; Helix, which has raised $353 million; and PathAI, which has raised $90.2 million.

2020 investments into precision medicine

The largest deal so far this year into a precision medicine company is Grail, which focuses on understanding the human genome to provide medical breakthroughs in oncology. The company announced a $390 million Series D financing round in may from new investors including Public Sector Pension Investment Board and Canada Pension Plan Investment Board, as well as two undisclosed investors, along with existing backers including Illumina. This brought its total funding tomore than $1.9 billion.

Other precision medicine companies that have raised funding this year include:

Be sure tocheck out theHealthcare in Politicsevent tomorrow(register forhere!)where multiple panels of experts, policy makers and lawmakers who will be on hand to discuss topics related to healthcare policy and decision making, including the role of precision medicine in the pandemic response.

(Image source: hdfgroup.org)

The rest is here:
The role of precision medicine in the pandemic response - VatorNews

"The 4 million mark is unfathomable. It boggles the mind, and it takes your breath away," a spokesperson for Cal Fire said.

Speaker 1: 00:00 California's disastrous wildfire season is now one for the record books. Roughly 4 million acres have burned that is far and away. The largest area destroyed in one season in modern California history. Climate change has been named as the major culprit in the state's bigger, hotter, faster moving wildfires in recent years, but a new report finds another and potentially manageable cause of these tremendous fires. That is where California is building new homes and the fire safety measures required in that construction. Joining me is reporter Elizabeth wile co author of an investigative report on wildfire and California housing policy published by pro Publica and Elizabeth. Welcome to the program. Thank you so much. Attention has been given to climate change as the crucial element in our devastating wildfires and rightly so, but what role does back country development play in sparking those fires?

Speaker 2: 01:02 Well, it plays a very large role. Um, climate change, of course, underlies this, all our heating planet and weather patterns are making it worse, but where humans live in our environment makes a tremendous difference in both where wildfires start, how many homes and lives are lost in those fires, how difficult those fires are to fight once they do start and how possible it is to manage the landscape well in a sort of preventative medicine way before fires started all.

Speaker 1: 01:38 And in your article, there's this figure that 95% of wildfires are caused by humans.

Speaker 2: 01:44 Yes. So the landscape does need to burn. California is a Mediterranean landscape and fire is a natural part of that landscape, but yes, 95% of fires are sparked by human. Someone drives down the road, a spark flies from something, somebody start to barbecue. As we all know, PG and E has started an awful lot of fires in the state. So the ignitions almost always are human caused. So when you have more humans living in an environment, the more likely it is that fires will start.

Speaker 1: 02:21 What's driving the development of homes in the back country or the wild land, urban interface area as it's

Speaker 2: 02:29 Yes, it's a mouthful. The wild land, urban interface. Well, the California has a housing crisis, as we all know. So the state desperately needs housing housing in a lot of coastal urban centers is extremely expensive. So people for financial reasons often move further and further away from those cities, uh, into areas that are now known as the wifi, the wild land, urban interface, and of those areas are often beautiful and people like living there. So there are many reasons people are getting pushed outward, but housing policy is a very large part of it.

Speaker 1: 03:09 When housing developments are planned, is there any state requirement that the wildfire risk needs to be assessed?

Speaker 2: 03:16 No, there are many different requirements and different municipalities, but this week Newsome vetoed a bill that for the first time would have made wildfire risks are part of what's known as the housing allocation process. It's very detailed in arcane and that part is not important. But as of now, wildfire is not whilst our risk is not considered in warehousing needs to be developed in California.

Speaker 1: 03:44 And the experts you spoke with said that it's really necessary to have a requirement at the state level about that. What is their reason?

Speaker 2: 03:53 Well, most, most housing decisions are made on the local level and therefore are very influenced by local politics. So for better or worse, a lot of more affluent suburbs and cities are very resistant to housing. There are a lot of underpinnings to this, but people will say traffic is already bad and their schools are already underfunded and their public transportation already. Isn't good enough. And many other reasons that often housing is resisted. So that becomes part of the issue at the local level, that if you leave it up to the locals and they don't want housing, it won't get built. But if there's state oversight sort of looking at the big picture in California and what needs to happen, we might move in the right direction more quickly now. Okay.

Speaker 1: 04:42 In your report, you say that it would not be possible to stop people from living in these remote areas, 11 million people in the state live in the wild land, urban interface, but are there ways to make the houses safer?

Speaker 2: 04:56 Yes. There are many ways to make the houses safer. And I, and I highly recommend to listeners if they live in a fire prone area to just, you know, look it up. But the first and most important thing to do is make sure you have a good roof, that you have a roof that is flame resistant, most houses burn, because embers blow in the wind and land on somebody's roof. And the house burns down as fire people often like to say, houses don't burn up. They burn down. So that's the first thing. And then people will find that they should clear vegetation out from around their houses. So if an Ember flies, the house is less likely to burn. There are a lot of fairly simple things that homeowners can do to make their own home safer. And a lot of experts believe that the community level of organization is really the most important thing relative to keeping our neighborhood safe. That if one house burns, the next is more likely to burn, but if your neighborhood can get together and everybody make your homes, fire safe together, you'll really put yourself at far less risk.

Speaker 1: 06:06 I have been speaking with pro public, a reporter, Elizabeth Weil and Elizabeth. Thank you so much for speaking with us. Thank you.

Visit link:
California Wildfires Have Burned 4 Million Acres And The Season Isn't Over Yet (KPBS Midday Edition Segments) - KPBS

Donald Trump has often been criticized for failing to follow through on promises. His latest promise, in a video clip posted to his Twitter feed, is that older Americans in an age range to be particularly vulnerable to COVID-19 will have the same medical treatment he received, at no cost. With reports that Joe Biden crossed the critical 270 elector vote mark, Trump described himself as capable of handling the crisis, and his opponent as unable to do so.

In the clip, Trump offers no plan for how he will provide this, doesnt say whether the treatment will be accessible to all Americans or just senior citizens, and doesnt address whether any other medical care, including preventative care, would be provided. Instead, he admits he was very sick when he went into the hospital Friday (a sharp contrast with the previous statements insisting it was merely a precaution), and that the medications provided, including experimental treatments that are not yet publicly available, worked for him so quickly that he could have left the next day. Then he promises that hell make the same available to my favorite people in the world seniors, for free.

To my favorite people in the world seniors. Im a senior. I know you dont know that. Nobody knows that, the president begins. We have medicines right now I call them a cure, he says. I went into the hospital a week ago. I was very sick. He says that after taking the medications made available to him through Walter Reeds top-tier medical team, he could have walked out the next day. Sooner.

He promises these treatments will be available immediately, and takes credit.

To seniors, he says, They like to say youre vulnerable. Youre not vulnerable. Youre the least vulnerable. But for this one thing, you are vulnerable. And so am I. But I want you to get the same care that I gotYoure gonna get the same medicine, youre gonna get it free. No charge! And were gonna get it to you soonWere gonna take care of our seniors, all free. He does not offer any specifics about when immediately might be, or what kind of plan hes proposing to make the treatments available.

Trump then transitions into bashing his opponent in the 2020 election.

The president was checked into Walter Reed last Friday, assuring the public it was just a precaution. Since then, information released about his diagnosis, timeline, and treatment has included contradictions, and the White House has refused to state when Trumps last negative COVID-19 test was. Though he is still within the 10-day quarantine period, the president has been releasing videos, maskless, apparently filmed outside the White House. Its not clear whether he is still on the steroid treatment he began receiving while in the hospital.

Read the original here:
Donald Trump Promises Seniors The Same Care He Got, For Free, Admits He Was "Very Sick" As Election Looms - HillReporter.com

From Women's Health

Face masks might help protect against the flu in addition to novel coronavirus.

The CDC doesn't officially recommend face masks for flu prevention, but does point to other "everyday preventative measures."

Doctors reiterate that masks can prevent respiratory droplets from spreading, including for both the flu and COVID-19.

Sure, people wear face masks these days mostly to help prevent the spread of COVID-19. But now experts say there might be an added benefit of wearing your mask when out in public: It could lower your odds of contracting the flu.

Like COVID-19, the flu is a virus thats mainly spread through infected respiratory droplets. Wearing a mask will likely decrease transmission of the flu as well, says Richard Watkins, MD, an infectious-disease physician in Akron, Ohio, and a professor of internal medicine at Northeast Ohio Medical University.

Rajeev Fernando, MD, an infectious-disease expert in Southampton, N.Y., expects that the 2020-21 flu season will actually be milder than usual because of coronavirus-prevention methods, including widespread mask wearing. Its the same concept as preventing the spread of COVID-19, he says. Masks can help prevent respiratory droplets from spreading.

That being said, you should still plan on getting a flu shot and practicing other flu prevention methods this year. Here's what you need to know about protecting yourself from the fluvia face masks and other measuresthis year.

FWIW: The Centers for Disease Control and Prevention (CDC) does not currently list wearing a face mask in its main recommendations for preventing the spread of the flu. Instead, the CDC recommends avoiding close contact with people who are sick, covering your coughs and sneezes, washing your hands well with soap and water, avoiding touching your eyes, nose, and mouth, and cleaning and disinfecting objects that could be contaminated with the viruses that cause the flu.

Story continues

However, the CDC does point people to everyday preventative measures for stopping the spread of COVID-19 as part of its tips for preventing the spread of the flu. And among those measures is advice to wear a face mask whenever you go out.

Medical staff wear surgical masks when treating flu patients, Fernando says, and a cloth face mask can likely offer at least some level of protection. And if someone who has the flu wears a mask and the people around them also wear a mask, the odds of the infected person making others sick drops dramatically, Fernando says.

The CDC specifically says that getting vaccinated against the flu this season is more important than ever and lists these as important reasons to get your shot:

It can reduce your risk of catching the flu, and of being hospitalized or dying from the flu if you do happen to contract it.

Getting a flu vaccine can save healthcare resources for the care of people who have COVID-19.

At this point, I would recommend as many preventive measures that we know are successful, Fernando says. Theres really no reason not to get your flu shot. We will have a weaker flu season if everyone does that.

And, if you continue to practice known ways of preventing the spread of COVID-19, like wearing your mask, avoiding crowds as much as possible, social distancing, and washing your hands regularly, your odds of contracting the fluand COVID-19should plummet, Watkins says.

Sounds like a win-win.

You Might Also Like

View original post here:
A Face Mask Might Help Protect You Against The Flu This Year - Yahoo Lifestyle

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as theyre published.

Monday morning, Sept. 28, California woke up sweaty, devastated, even shocked to find the state burning again. But if were honest, and to our great shame, no one was surprised. Wed seen this horror movie in this town. Three years ago, wildfire killed 25 people in Sonoma County. Now the Glass Fire was there, again, burning toward Santa Rosa. At 12:30 a.m., a string of seniors stood in line, many in pajamas, waiting to board an evacuation bus from their retirement home. A tiny woman with a roller bag stooped over her walker. A man in a red shirt leaned on his red cane. A woman in a purple robe and magenta slippers sat in her wheelchair, a white teddy bear in her lap. They disembarked at the Santa Rosa Veterans Memorial Auditorium. But then at 2:48 a.m., before the slumped crowd, a young man climbed on a folding chair and announced: The fire was moving too fast toward them. Time to move again.

Farther east, the Butte County sheriff issued an evacuation warning for the entire town of Paradise. The Camp Fire killed 85 people in Paradise less than two years ago. Many survivors, including the former mayor, spent the night trying and failing to sleep in one of Paradises 434 newly rebuilt homes.

It is all too close, too soon: the propane tanks exploding, the safety-vest orange sky. By daylight, that sky rained chunks of ash, like dead moths. Many Californians would have felt less triggered by locusts.

California, as we all now know, is going to burn.

The ecosystem here depends on fire to stay healthy. OK, fine.

We suppressed that fire for a hundred-plus years, and now were living with a deathly backlog of kindling. Not fine, but thats going to take decades to fix.

The climate crisis has warmed and dried that tinder, leading to five of the six largest fires in California history just this year. Not fine at all, but the time frame of remedying this uhh lets just put that to the side.

Which leaves us with the one thing we could be doing to keep wildfire from destroying homes and lives: get a whole lot smarter about where and how we build.

Housing is the megafire-sized climate issue that lawmakers in California keep failing to adequately address even though when asked directly how important housing is to California climate policy, Kate Gordon, Gov. Gavin Newsoms senior climate policy adviser, told me, Oh, its HUGE. Yet it remains intractable.

Adam Millard-Ball, a professor who studies urban planning and environmental economics at the University of California, Santa Cruz, told me, Its absolutely the weak link in the states climate policy. Affluent urban areas and suburban areas have been incredibly successful at pulling up the drawbridge, as Millard-Ball put it, blocking new housing and pushing Californians to live in evermore remote communities, often in whats known as the wildland urban interface. (WUI, the shorthand for this area where humans meet nature, is pronounced woooeeee.) It kicks off a pernicious cycle. Once there, people drive more, increasing emissions. And thanks to emissions globally, those areas are burning more than ever before. In August, Millard-Ball himself recently had to evacuate his home because of the CZU August Lighting Fire Complex.

So with that as a backdrop. ... he said. Californias housing dysfunction has been thrown into really tragic, stark relief for the last couple of months.

Subscribe to the Big Story newsletter.

California leads the country on most climate issues; its showpiece is green transportation. Just last week, amid this latest round of fires, Newsom promised to phase out new gas-only cars by 2035. But when it comes to addressing the root causes why people have to drive in the first place. ... Millard-Ball trailed off. Not much happens. Or not much good.

On Wednesday night, Newsom vetoed a bill that would have nudged Californians to stop putting new housing in high fire-risk zones. The piece of legislation had overcome a yearlong delay, appeased initial detractors including the development lobby and passed the legislature by wide margins before flaming out at the eleventh hour on the governors desk.

It was, as original sponsor Sen. Hannah-Beth Jackson, a Democrat from Santa Barbara, acknowledged when the California Senate Housing Committee began debating it in April 2019, not exactly the sexiest stuff in the world. But it had two important goals: One, to identify existing structures highly vulnerable to burning in wildfire and make plans to retrofit them. (This was not politically complicated, as the measure did not even include funding.) Two, to ease pressure to develop in the parts of California with the highest wildfire risk. To date, no legislation related to wildfires or any other climate-related hazard impacts Californias arcane housing allocation system. (That system tells each region how much housing its required to build over a stretch of five or eight years.) But once wildfire risk is codified as a valid reason not to build, whats next? Extreme heat? Nick Cammarota, with the California Building Industry Association, articulated that viewpoint when he called the bill a housing killer.

We dont want to have gentrification. We dont want to have seismic risk. We dont want to have sea level rise or wetlands, or ag land preservation or floods, or toxics. Or you name it, he continued. The entire state is covered with imperfect places to build.

Yet dealing with WUI development, according to fire pros like former California State Fire Marshal Kate Dargan, is the most urgent fire question in the state.

Newsom did sign legislation to improve emergency response and preparedness efforts. But his veto of what was a pretty modest bill felt inauspicious to climate policy wonks who pay attention to such things. At this moment, it is extremely disappointing to hear that @GavinNewsom decided not to sign #sb182, Michael Wara, director of the Climate and Energy Policy Program at Stanford University, tweeted at 10:31 p.m. on Wednesday. The housing crisis enormously complicates decisions not to build anywhere. But solutions to Californias housing production needs are not now nor will they in future be in the WUI. A half-hour later he tweeted again, appalled by Newsoms refusal to back away from sprawl that must ultimately be defended from wildfire at enormous cost in treasure, and hopefully not in blood.

What will it take to create change? If we cant do it now, with the impetuses of the housing crisis and the wildfire. Millard-Ball said. Then he trailed off. It would be incredibly sad to sit back and do nothing.

This is the basic WUI problem: Houses are essentially big piles of fuel. Houses in the WUI also mean people in the WUI, and people ignite over 95% of California wildfires. Houses further increase risk to lives and structures by making it difficult for land managers to do prescribed burns. Once wildfires grow large, houses increase risks for firefighters. Houses in the WUI cost a fortune to defend.

Max Moritz, a wildfire specialist at University of California Cooperative Extension at the Bren School in Santa Barbara, began focusing intently on the WUI problem six years ago. Hed been creating fire probability maps under different climate change scenarios, and his data on fuel included plants that could burn, but not buildings. He found that nearly a quarter of the increased risk that appeared to be due to climate change was in fact due to development. So in 2016, Moritz worked with a team of scientists to co-write a paper laying out why we need to include land use in the wildfire models. (I can send it to you if you want it. Its great bedtime reading.) Then Moritz pivoted to synthesizing the research on fire in the WUI. His goal was to lay out the facts for policymakers. Then maybe this stuff could get codified, he said. Because yeah, why isnt it? Why isnt it regulated?

After the 2009 Black Saturday fires in Australia that killed 173 people and destroyed 2,133 homes, the federal government launched a commission that found (among many other things) planning and building controls are crucial factors affecting safety. The Australians then instituted swift, sweeping changes. Among them: including bushfire risk in planning new development and making ember risk part of building codes. Yet, over the past seven years, wildfires in California have killed 193 people and destroyed nearly 50,000 structures, and the state has done comparatively little to fix the problem. We have these tragic, huge events. We have Black Saturday after Black Saturday and almost no movement on these things, Moritz said.

Hed hoped the research he and others had done on where and how we build in the face of climate change would spur bolder action. Man, youve got the chance here to establish your legacy, as a progressive leader, tackling a tough problem, he said, as if talking to Newsom shortly before the governor vetoed the bill. But hey, land use urban planning thats political. Thats tough, right? Yeah. We need some guts.

To protect a single home from wildfire in the WUI, this is your basic checklist. Defensible space. (No combustibles close to your home for sure in the first 5 feet. Newsom did sign a separate law on Tuesday mandating this for high fire severity zones.) Class A fireproof roof. Dual-paned windows. Remove flammables from under deck. Metal gutter covers. A mesh covering all vents.

But protecting a single home in the WUI is (with only some exaggeration) like being the only one in your family who wears a mask. Safety is inherently a community project, and fire experts, as a rule, freak out about their neighbors houses and yards. One has nightmares about wood shingle siding that ignites and flies off like an airfoil spreading fires. Another about mulch that lets embers smolder until a wind whips them into open flames that creep right up to peoples house walls. A third told me about ponderosa pines killed by bark beetles but not yet cut down. Have you ever had a real Christmas tree and burned it in February? he asked. They go off like napalm.

For Wara, of Stanfords Climate and Energy Policy Program, the zombies are the 20-foot-tall juniper bushes that line his neighbors house. Its a herd immunity thing, right? he said. Once your neighbors house catches fire and starts throwing embers, yours is probably next. I dont think people get that.

In the early 1970s, the National Commission on Fire Prevention and Control tackled the problem of indoor fire. This culminated in the America Burning report, which in turn led to the creation of the U.S. Fire Administration and an over 50% drop in indoor fires since 1980. But theres no such equivalent effort for wildfires. To help fix this, for the past two years, Alexander Maranghides, a fire protection engineer with the National Institute of Standards and Technology, or NIST, has been co-leading a detailed reconstruction of the Camp Fire that destroyed Paradise. (NIST plans to release its first of three 400-page reports this fall.) The outside fire problem is technically somewhere between one and two orders of magnitude more complex than the interior fire problem, Maranghides said. Those fires involve topography, weather, fuel conditions, fire-fighting response, on and on. Just defining the fire dynamics of embers alone is a huge task. The intention of this science is not to keep people from living in the WUI at all, which almost nobody thinks is feasible. The intention is to make the public and policymakers WUI literate and provide science and tools that could lead to the creation of cost-effective solutions, so we dont keep repeating the same tragic, expensive mistakes.

Wara pointed out that people are rebuilding in Coffey Park, a neighborhood in Santa Rosa that was nearly destroyed in 2017. And theyre doing all these things that are so avoidable. Like wood fences connecting the homes. Its like a vertical, combustible ember catcher! You just dont need to do that.

Heres the political problem: 11 million people, over a quarter of all Califorians, live in the WUI. We are not going to kick them out.

At the same time, the state is in a housing crisis, and Newsom staked his career on fixing it. In his inaugural address, in January 2019, he announced a Marshall Plan for housing and promised to build 3.5 million new affordable units by 2025. You could hear the tension between that promise and watching his state burn down in his veto Wednesday night. Wildfire resilience must become a more consistent part of land use and development decisions, he wrote. However, it must be done while meeting our housing needs.

Right now, the states climate priorities are skewed. California has focused on solar and wind and electric vehicles the sort of technology solution side of climate, she said. We havent focused as much on land use, Gordon, the Newsom adviser, admitted. This is an oversight, and the administration knows it, even refuses at times to act that way. As a state, were the one who pays for the disaster mitigation, right? Gordon said. Its just not sustainable. I mean, our entire budget will become about disaster response if we dont get ahead of this thing.

Without action at the state level, its hard to see how California achieves good climate housing policy. Local governments have a lot of power. Too much power, Millard-Ball, the UC Santa Cruz professor, argues. Cities can effectively ignore the climate crisis when theyre making certain decisions, he said. Like most cities in California have developed climate action plans, which are great in terms of things promoting waste reduction and street trees and energy efficiency. But they have said almost nothing about creating more walkable, transit-oriented places to live.

The situation is becoming dire. Insurers, losing a fortune in the WUI, are rapidly dropping homeowner policies. The hemorrhage of non-renewals grew so acute that Californias insurance commissioner essentially instituted a circuit-breaker halt and declared a one-year moratorium. But that may not be enough help for residents to afford to stay. As Mariposa County Supervisor Kevin Cann told me, You go on the FAIR Plan the California insurance policy of last resort and you realize, Holy smokes! I used to pay $1,200 a year and now Im going to pay $5,000. Thats a second mortgage.

The hard truth is: this is as it should be. WUI housing, with its true costs factored in, is not the bargain real estate agents refer to when they say, Drive until you qualify. Last year, the National Bureau of Economic Research, or NBER, published a paper detailing how taxpayers are subsidizing people living in high fire risk zones. How? Firefighting is expensive California may spend a billion dollars this year. A large percentage of that will go to defending private homes. This firefighting benefit is not negligible: NBER calculated it can exceed 20% of a propertys value. The very fact that firefighting is publicly funded decreases the incentive for WUI residents to fireproof their properties. Distorting the housing market further and creating moral hazard: Because much of firefighting budgets comes out of federal disaster funds, publicly funded fire response decreases the incentive for a city or state hello, California to create and enforce wildland building codes.

This pattern, according to NBER, will grow more pronounced with climate change.

The state would also save money if it took a preventative medicine approach and shifted more funds into fire prevention. Every dollar invested in risk mitigation typically saves six in disaster costs. Dargan, the former state fire marshal, who was a firefighter for 30 years and has a son working as a first responder right now, believes the state makes a mistake by not viewing fire prevention and suppression as the same thing. Mitigation and response just happen at different times on the continuum of solutions, she said. We have the worlds best response system in California. And that system works beautifully until a megafire erupts. Then that system fails. At that point, no matter how well theyre trained or how hard they work, firefighters are unable to focus on firefighting. All they can do is get people out ahead of time and even then were beginning to fail at greater numbers. We need a better plan. For taxpayers. For WUI residents, like those seniors evacuated from their homes after midnight in Santa Rosa on Monday and then evacuated from the evacuation center around 3 am. For people, including her son, on the front line.

Go here to see the original:
California Will Keep Burning. But Housing Policy Is Making It Worse. - ProPublica

Former Gov. Chris Christie has spent five days in the hospital being treated for the coronavirus with little word on how hes doing.

Christie is one of several people who spent time with President Donald Trumps inner circle who tested positive for COVID-19 over the last week. The former New Jersey governor was admitted into Morristown Medical Center on Saturday as a precaution because of his history with asthma.

At the time, Christie said he had mild symptoms. Since then, he and his doctors have been publicly silent about his treatment and condition. A source with knowledge of the governors case said only that he is in good spirits and is getting good care.

Its unclear if Christie, 58, is still in the hospital because his condition has gotten worse or if hes being held as a precaution. In addition to asthma, Christie has weight issues, two conditions that may put him at higher risk for complications from the virus. He also is the former governor.

Obviously, VIPs get VIP treatment, said Lewis Nelson, an emergency physician and chair of emergency medicine at the Rutgers New Jersey Medical School in Newark.

Nelson hasnt treated Christie and doesnt know the details of his case. But he said being a VIP can be a blessing and a curse in a hospital. A high-profile patient can get top notch care and speedy access to doctors and drugs other patients might not get, as President Donald Trump did during his hospitalization for COVID-19.

But they can also be held in the hospital longer than necessary.

They do tend to get over-managed and over-tested, Nelson said.

Christie is likely receiving some of the same treatments as other coronavirus patients who were ill enough to have to be admitted to a hospital. Heres what a COVID-19 patient might experience in the hospital, according to Nelson and Anne K. Sutherland, a pulmonologist who runs the intensive care unit at University Hospital in Newark:

Evaluation: Though Christie tweeted "I checked myself into Morristown Medical Center, most people dont get to just show up at the hospital when they test positive for COVID-19 and get a room like its a hotel, doctors said.

Coronavirus patients would likely be examined by a doctor who would check for fever, breathing difficulties and a low blood oxygen level, Nelson said. If the blood oxygen reading is 94% or below, the patient would likely be given oxygen and admitted to the hospital because that may be a sign they are headed for a crisis.

Patients with high risk factors, including being overweight, having diabetes or asthma, a heart condition or a chronic health condition, would be more likely to be hospitalized, Nelson said.

Access to drugs: While in the early days of the virus doctors were unsure what, if any, drugs to use to treat COVID-19, most hospitalized patients are now given remdesivir, an antiviral. The drug was first developed to treat Ebola but has become a go-to drug for hospitalized coronavirus patients in recent months.

There is not definitive proof remdesivir works, but there is also no proof it does any harm, Nelson said. So, many doctors are using it to treat COVID-19 patients, especially those who are older, overweight or have other high-risk factors.

We tend to use remdesivir fairly liberally in these people, Nelson said.

Patients may also be treated with anti-inflamatory drugs and steroids, like the dexamethasone steroid Trump was given in the hospital. Again, doctors say there are no studies proving they work. But doctors have found them effective in many patients.

In New Jersey hospitals, some COVID-19 patients may also be asked to participate in one of several clinical trials testing the effectiveness of other new drugs and treatments.

It remains unclear whether many treatments, including the Regeneron monoclonal antibody cocktail Trump was given, are working. But many doctors and patients are willing to experiment, Nelson said.

We dont know the best answer. Thats the problem, Nelson said.

Asthma concerns: Asthma is considered one of the conditions that might raise a patients risk for having a severe case of COVID-19. But asthma sufferers, like Christie, probably would not receive any special drugs or monitoring.

They would not be treated any differently, said Sutherland, a pulmonologist and associate professor at the Rutgers New Jersey Medical School.

The preliminary data has shown that having asthma doesnt increase the severity of the coronavirus or increase a patients risk of death, Sutherland said. But more extensive studies are needed. For now, doctors keep a close eye on asthma patients.

An isolated room, with the possibility of visitors: New Jersey hospitals no longer have the crush of COVID-19 patients that did in the early months of the pandemic. These days, patients will likely have their own rooms in an isolated part of the hospital in units reserved for coronavirus patients, the doctors said.

Were able to sequester people, Nelson said.

Patients who are not on ventilators are usually able to eat meals, if they feel well enough, and walk around their rooms. They are not usually permitted to walk the halls or go to other areas of the hospital.

Hospitals have lifted their bans on visitors to COVID-19 patients, so some patients are able to see their families from a safe distance.

Constant monitoring: Coronavirus patients will be hooked up to multiple monitors and have a steady stream of nurses and doctors checking on them, Sutherland said.

They will likely have a pulse oximeter checking their oxygen levels continuously and a heart monitor to check for cardiac complications. They will have their blood pressure monitored every one to four hours, along with their respirator rate.

Doctors will also be monitor patients and give them preventative drugs for blot clots in the legs and lungs, a dangerous complication found in some COVID-19 patients, Sutherland said.

Those with breathing difficulties might need supplemental oxygen or a high-flow nasal oxygen machine, a devise that looks similar to a sleep mask used by people with sleep apnea, Sutherland said. As a last resort, patients will be put on a ventilator to keep them breathing if the virus attacks their lungs.

Watching the timeline: Patients who are able to breathe on their own should not expect a long stay in hospital unless they have other complications, the doctors said.

If youre not on a ventilator ... you are usually going to be gone from the hospital in a few days, Nelson said.

Doctors who have treated many coronavirus patients say theyve spotted a pattern in people who develop severe cases. The turning point for many is between five and eight days after they get sick.

Thats when they would take a turn for the worse, Sutherland said.

Most people who make it past the 10-day mark without severe symptoms dont get any sicker, she added. But every case is different and there are no guarantees.

Thank you for relying on us to provide the journalism you can trust. Please consider supporting NJ.com with a subscription.

Kelly Heyboer may be reached at kheyboer@njadvancemedia.com.

More here:
Chris Christie still hospitalized with COVID-19: Heres the type of treatments doctors say he may be getting - NJ.com

HENDERSON, Nev. andWASHINGTON, Oct. 8, 2020 /PRNewswire/ --Research Solutions/Reprints Desk(NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations,today announced that ithas partnered withBIO Business Solutionsto help life sciences companies save time and money on scholarly literature access via its award-winning Article Galaxyresearch platform. Operated by the Biotechnology Innovation Organization (BIO), BIO Business Solutions is the industry's largest cost savings purchasing program.

More than 4,500 member companies worldwideincluding biotechnology and biopharmaceutical firms, medical device firms, academic institutions, state biotechnology centers, and related organizationstogether save more than $511 million annually through the BIO Business Solutions program.

"Just like BIO we are focused on fostering collaboration and education to advance biotechnology," saidRogier van Erkel, Chief Commercial Officer at Research Solutions. "With fast and lowest-cost access to scientific literature, Research Solutions aims to contribute to accelerated innovation and growth across all Life Sciences companies."

Key benefits for BIO member companies include:

Biotech and pharmaceutical companies that use the BIO Business Solutions program for a reduced-price Article Galaxy subscription will further benefit from the platform's array of time- and cost-saving features, including:

"BIO fosters innovation in many ways," said Kelly Martin, Vice President of Business Strategies at BIO. "Our partnership with Research Solutions will make scientific literature more accessible and affordable to our member companies that are developing innovative breakthroughs in the life sciences sector."

For more information about Research Solutions' participation in the BIO Business Solutions program, or to sign up for a free trial of Article Galaxy, please visit bio.org/save, send an email to bio@researchsolutions.comor call us at +1 (310) 477-0354.

About Research Solutions and Reprints DeskResearch Solutions/Reprints Desk (NASDAQ: RSSS) is a pioneer in providing seamless access to scientific content. It simplifies how organizations andindividualresearchers discover, acquire, and manage scholarly journal articles, book chapters, patents, and other documents in scientific, technical, and medical (STM) research.More than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on Article Galaxy, a cloud-based SaaS research platform, for simplified and lowest cost access to the latest scientific research and data. Featuring an ecosystem of app-like Gadgets for a personalized research experience, Article Galaxy offers individual as well as enterprise plans, coupled with unparalleled, 24/7 customer support.For more information and details, please visit http://www.researchsolutions.comandwww.reprintsdesk.com

About BIO AssociationBIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. For more information visit: http://www.bio.org, follow us on Twitter @IAmBiotech, or find us on LinkedIn

Forward-Looking StatementsCertain statements in this press release may contain "forward-looking statements" regarding future events and our future results.All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding transforming how customers find and access full-text articles. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.

View original content to download multimedia:http://www.prnewswire.com/news-releases/research-solutions-partners-with-bio-to-bring-one-click-scientific-literature-access-to-the-biotech-industry-301148240.html

SOURCE Research Solutions, Inc.

Read this article:
Research Solutions Partners with BIO to Bring One-Click Scientific Literature Access to the Biotech Industry - BioSpace

SAN DIEGO--(BUSINESS WIRE)--Allele Biotechnology and Pharmaceuticals, Inc. (Allele), a San Diego-based company focused on developing and adapting cutting edge technology for clinical and therapeutic use, filed two patent infringement lawsuits today one in New York against Regeneron Pharmaceuticals and the other in California against Pfizer and BioNTech. Both complaints address the infringement of Alleles patented mNeonGreen technology, an important reagent used in the development of therapeutics for COVID-19.

Alleles mNeonGreen protein is considered the worlds brightest monomeric fluorescent protein, and the technology behind that protein was patented in 2019. Prominent scientific journals have touted the use of mNeonGreen as the gold standard for use in assays testing neutralizing antibody and vaccine candidates. Regeneron, Pfizer, and BioNTech used mNeonGreen commercially without authorization from Allele.

I am pleased that mNeonGreen has played a pivotal role in the fight against COVID-19. In no way does Allele want to prohibit, or slow down development of vaccines or therapeutics discovered using this technology, says Dr. Jiwu Wang, Founder and CEO of Allele. Our goal is to have these companies recognize, as many others have before them, the hard work that went in to developing this technology and to respect our intellectual property.

Hundreds of organizations and universities have active licenses to use Alleles mNeonGreen technology. According to the complaint, Allele reached out to Regeneron on multiple occasions to negotiate a license on reasonable terms, but all of its requests went unanswered. In fact, no defendant sought any permission in advance of using mNeonGreen to obtain breakthrough successes in developing and testing their vaccines.

The purpose of these lawsuits is to maintain Allele's patent rights and to ensure that an agreement can be put in place to protect the rights of current and future licensees, says Dan Catron, Executive Director, Licensing and Business Development for Allele.

Perkins Coie LLP is representing Allele in the New York filing. Troutman Pepper Hamilton Sanders LLP is representing Allele in the California lawsuits.

About Allele Biotechnology and Pharmaceuticals Inc.

Established in 1999, Allele Biotechnology has focused on developing and adapting cutting edge technology for clinical and therapeutic use. Allele has worked on biological advancements that have been at the forefront of molecular biology research, including RNA interference, fluorescent proteins, induced Pluripotent Stem Cells (iPSCs), and camelid-derived, single-domain nanoantibodies. With the advent of the global pandemic, Allele initiated the development of a series of llama nanoantibodies against SARS-CoV-2, the virus responsible for COVID-19. To learn more, go to https://www.allelebiotech.com.

Visit link:
Allele Biotechnology and Pharmaceuticals Files Two Lawsuits for Patent Infringement for the Unauthorized Use of mNeonGreen in Development and Testing...

Arcturus Therapeutics Holdings Inc (ARCT) is near the top in its industry group according to InvestorsObserver. ARCT gets an overall rating of 66. That means it scores higher than 66 percent of stocks. Arcturus Therapeutics Holdings Inc gets a 82 rank in the Biotechnology industry. Biotechnology is number 23 out of 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 66 means the stock is more attractive than 66 percent of stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

Arcturus Therapeutics Holdings Inc (ARCT) stock is trading at $53.50 as of 11:40 AM on Thursday, Oct 8, an increase of $2.58, or 5.07% from the previous closing price of $50.92. The stock has traded between $51.70 and $55.13 so far today. Volume today is low. So far 331,678 shares have traded compared to average volume of 713,777 shares.

Click Here to get the full Stock Score Report on Arcturus Therapeutics Holdings Inc (ARCT) Stock.

Go here to read the rest:
Is Arcturus Therapeutics Holdings Inc (ARCT) the Top Pick in the Biotechnology Industry? - InvestorsObserver

Plant Biotechnology Services Market Report Delivering Growth Analysis with Key Trends of Top Companies (2020-2026)

A comprehensive research study on the Plant Biotechnology Services Marketwas recently published by Market Report Expert. This is an up-to-date report, covering the current COVID-19 impact on the market. The Coronavirus (COVID-19) has affected every aspect of life globally and thus altering the global market scenario. The changes in the market conditions are drastic. The swiftly changing market scenario and initial and future assessment of the impact on Plant Biotechnology Services market is covered in the report.The Plant Biotechnology Services Market report is a precise and deep-dive study on the current state that aims at the major drivers, market strategies, and imposing growth of the key players. Worldwide Plant Biotechnology Services Industry also offers a granular study of the dynamics, segmentation, revenue, share forecasts, and allows you to make superior business decisions. The report serves imperative statistics on the market stature of the prominent manufacturers and is an important source of guidance and advice for companies and individuals involved in the Plant Biotechnology Services industry.

The Global Plant Biotechnology Services Market poised to grow from US$ XX million in 2020 to US$ XX million by 2026 at a compound annual growth rate (CAGR) of XX% during the projection period of 2020-2026.

An Outline of the Major Key Players covered in this Report:

Thermo Fisher Scientific Inc., Agilent Technologies, GenScript Biotech Corporation, Eurofins Scientific SE

Get Free LatestPDF Template of this Report(Including Covid-19 impact analysis on overall industry Forecast, Size, Share, CAGR and more.)@ https://www.marketreportexpert.com/report/Plant_Biotechnology_Services/13966/sample

Note: We can also provide market report in German/French Language.

The report puts together a succinct analysis of the growth drivers influencing the current business scenario across various regions and countries. Substantial information pertaining to the industry analysis size, share, application, and statistics are summed in the report in order to present a collaborative prediction. Additionally, this report encompasses a precise competitive analysis of major market players, innovative companies, and their strategies during the projection timeline.

The latest report on the Plant Biotechnology Services Market consists of an analysis of this industry and its type, application, and other segments. As per the report, the market is estimated to gain significant returns and register substantial y-o-y growth during the forecast period of 2020-2026.

Majortype, primarily split into

Genomics ServicesAnalytical ChemistryCellular ImagingForage AnalysisTransformation Services

Major applications/end users, including

Research InstitutesPharmaceuticals CompaniesBiotechnology Companies

According to the report, the study offers details regarding the valuable estimations of the market such as market size, sales capacity, and profit projections. The report documents factors such as drivers, restraints, and opportunities that impacts the remuneration of this market.

Feel Free! Ask Our Industry Expert For Discount on this Report(Note: Our reports include the analysis of the impact of COVID-19 on this industry. Our updated sample pages shows impact of Covid-19 on Industry trends. Also we are offering 20% discount.): https://www.marketreportexpert.com/report/Plant_Biotechnology_Services/13966/inquiry

The research offers an analysis of the geographical landscape of the Plant Biotechnology Services Market, which is divided into regions such as North America, Europe, Asia Pacific, South America, and the Middle East & Africa. The segment includes data about several parameters related to the regional contribution such as market share, application share, type share, key companies in respective regions, market share of key companies in regional market, growth rate and revenue of the regional market, sales, production, and consumption of the respective Plant Biotechnology Services market.

Major Highlights of TOC Covers:

Plant Biotechnology Services Market 2020, Plant Biotechnology Services Market size, Plant Biotechnology Services Market share, Plant Biotechnology Services Market analysis, Plant Biotechnology Services Market forecast, Plant Biotechnology Services Market trends, Plant Biotechnology Services Market Research report, Plant Biotechnology Services application, Plant Biotechnology Services Trends, Plant Biotechnology Services Market growing CAGR, Plant Biotechnology Services Market Competitive Landscape, Plant Biotechnology Services Market Growth

Information related to the growth rate, revenue, sales, production, consumption, during the forecast period is included in the report. The Plant Biotechnology Services Market report claims that the industry is projected to generate significant revenue and sales during the forecast period. The report consists of information related to the market dynamics such as challenges involved in this vertical, growth opportunities, and driving factors affecting the market.

About Us

Market Report Expert is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports.

Contact USJames ThompsonMarket Report ExpertPhone: +1-816-301-6258Email inquiry@marketreportexpert.comWeb:-https://www.marketreportexpert.com

Read more:
Plant Biotechnology Services Market Increasing Demand with Leading Player, Comprehensive Analysis 2026| Thermo Fisher Scientific Inc., Agilent...

A rating of 82 puts Denali Therapeutics Inc (DNLI) near the top of the Biotechnology industry according to InvestorsObserver. Denali Therapeutics Inc's score of 82 means it scores higher than 82% of stocks in the industry. Denali Therapeutics Inc also received an overall rating of 66, putting it above 66% of all stocks. Biotechnology is ranked 25 out of the 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Denali Therapeutics Inc (DNLI) stock is trading at $38.82 as of 2:13 PM on Wednesday, Oct 7, a rise of $1.37, or 3.66% from the previous closing price of $37.45. The stock has traded between $37.75 and $39.54 so far today. Volume today is 434,019 compared to average volume of 574,304.

Click Here to get the full Stock Score Report on Denali Therapeutics Inc (DNLI) Stock.

See the article here:
Is Denali Therapeutics Inc (DNLI) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

The 67 rating InvestorsObserver gives to Blueprint Medicines Corp (BPMC) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 84 percent of stocks in the Biotechnology industry, BPMCs 67 overall rating means the stock scores better than 67 percent of all stocks.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Blueprint Medicines Corp (BPMC) stock is trading at $99.43 as of 3:25 PM on Wednesday, Oct 7, a gain of $2.88, or 2.98% from the previous closing price of $96.55. The stock has traded between $97.13 and $100.52 so far today. Volume today is 381,700 compared to average volume of 494,247.

Click Here to get the full Stock Score Report on Blueprint Medicines Corp (BPMC) Stock.

View original post here:
Is Blueprint Medicines Corp (BPMC) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

A rating of 3 puts Aptorum Group Ltd (APM) near the bottom of the Biotechnology industry according to InvestorsObserver. Aptorum Group Ltd's score of 3 means it scores higher than 3% of stocks in the industry. Aptorum Group Ltd also received an overall rating of 8, putting it above 8% of all stocks. Biotechnology is ranked 25 out of the 148 industries.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Aptorum Group Ltd (APM) stock is trading at $2.79 as of 1:12 PM on Wednesday, Oct 7, an increase of $0.10, or 3.72% from the previous closing price of $2.69. The stock has traded between $2.70 and $2.99 so far today. Volume today is 2,313,374 compared to average volume of 2,976,804.

Click Here to get the full Stock Score Report on Aptorum Group Ltd (APM) Stock.

Read the original:
Is Aptorum Group Ltd (APM) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

A rating of 54 puts Wave Life Sciences Ltd (WVE) near the middle of the Biotechnology industry according to InvestorsObserver. Wave Life Sciences Ltd's score of 54 means it scores higher than 54% of stocks in the industry. Wave Life Sciences Ltd also received an overall rating of 51, putting it above 51% of all stocks. Biotechnology is ranked 22 out of the 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Wave Life Sciences Ltd (WVE) stock is trading at $8.96 as of 11:28 AM on Tuesday, Oct 6, a gain of $0.45, or 5.29% from the previous closing price of $8.51. The stock has traded between $8.66 and $9.14 so far today. Volume today is below average. So far 748,888 shares have traded compared to average volume of 1,771,971 shares.

Click Here to get the full Stock Score Report on Wave Life Sciences Ltd (WVE) Stock.

Read more from the original source:
Where Does Wave Life Sciences Ltd (WVE) Stock Fall in the Biotechnology Field? - InvestorsObserver

The 48 rating InvestorsObserver gives to LogicBio Therapeutics Inc (LOGC) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 51 percent of stocks in the Biotechnology industry, LOGCs 48 overall rating means the stock scores better than 48 percent of all stocks.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 48 would rank higher than 48 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

LogicBio Therapeutics Inc (LOGC) stock is trading at $7.64 as of 11:48 AM on Wednesday, Oct 7, a gain of $0.81, or 11.86% from the previous closing price of $6.83. The stock has traded between $6.89 and $7.92 so far today. Volume today is low. So far 186,868 shares have traded compared to average volume of 257,546 shares.

Click Here to get the full Stock Score Report on LogicBio Therapeutics Inc (LOGC) Stock.

Go here to read the rest:
Is LogicBio Therapeutics Inc (LOGC) a Winner in the Biotechnology Industry? - InvestorsObserver